Johnson Investment Counsel Inc Eli Lilly & CO Transaction History

Johnson Investment Counsel Inc

$9.44 Billion
Q2 2024

A detailed history of Johnson Investment Counsel Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 33,847 shares of LLY stock, worth $30.8 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

33,847

Previous 34,748 2.59%

Holding current value

$30.8 Million

Previous $27 Million 13.36%

% of portfolio

0.32%

Previous 0.3%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $653,107 - $819,045	-901 Reduced 2.59%	33,847 $30.6 Million
Q1 2024 May 09, 2024	BUY	$592.2 - $792.28 $5.68 Million - $7.6 Million	9,588 Added 38.11%	34,748 $27 Million
Q4 2023 Feb 07, 2024	BUY	$525.19 - $619.13 $149,153 - $175,832	284 Added 1.14%	25,160 $14.7 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $129,105 - $177,992	-297 Reduced 1.18%	24,876 $13.4 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $146,609 - $196,033	-418 Reduced 1.63%	25,173 $11.8 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $119,592 - $140,455	-385 Reduced 1.48%	25,591 $8.79 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $418,015 - $487,071	1,300 Added 5.27%	25,976 $9.5 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $29,351 - $33,449	99 Added 0.4%	24,676 $7.98 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $220,475 - $258,870	791 Added 3.33%	24,577 $7.97 Million
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $133,773 - $166,246	-570 Reduced 2.34%	23,786 $6.81 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $17,088 - $21,207	76 Added 0.31%	24,356 $6.73 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $70,690 - $86,994	-319 Reduced 1.3%	24,280 $5.61 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $109,954 - $142,225	-609 Reduced 2.42%	24,599 $5.65 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $62,934 - $81,471	-383 Reduced 1.5%	25,208 $4.71 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $157,856 - $208,882	-1,210 Reduced 4.51%	25,591 $4.32 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $32,168 - $37,208	220 Added 0.83%	26,801 $3.97 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $398,892 - $480,062	-2,924 Reduced 9.91%	26,581 $4.36 Million
Q1 2020 May 20, 2020	SELL	$119.05 - $147.35 $28,095 - $34,774	-236 Reduced 0.79%	29,505 $4.09 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $207,104 - $256,516	-1,937 Reduced 6.11%	29,741 $3.91 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $62,685 - $68,185	-587 Reduced 1.82%	31,678 $3.54 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $37,557 - $43,839	-339 Reduced 1.04%	32,265 $3.57 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $219,614 - $258,502	-1,973 Reduced 5.71%	32,604 $4.23 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $401,572 - $449,882	3,792 Added 12.32%	34,577 $4 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $90,925 - $113,641	-1,059 Reduced 3.33%	30,785 $3.3 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $44,133 - $50,651	-583 Reduced 1.8%	31,844 $2.72 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $97,808 - $115,456	-1,318 Reduced 3.91%	32,427 $2.51 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $129,711 - $139,129	-1,583 Reduced 4.48%	33,745 $2.85 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $2.72 Million - $3.02 Million	35,328	35,328 $3.02 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.

Account

Johnson Investment Counsel Inc Eli Lilly & CO Transaction History